TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Bronstein, Gewirtz & Grossman Llc
TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Law firm announces class action lawsuit against Telix Pharmaceuticals for allegedly making false statements about prostate cancer therapeutic candidates and supply chain quality during February-August 2025.

Insights
COST   positive

Top holding in both ETFs, suggesting strong market position in consumer staples


TLX   negative

Lawsuit alleges company made materially false and misleading statements about its business progress, therapeutic candidates, and supply chain quality, suggesting potential corporate misconduct